A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD

Renton, Alan E., Majounie, Elisa, Waite, Adrian, Simón-Sánchez, Javier, Rollinson, Sara, Gibbs, J. Raphael, Schymick, Jennifer C., Laaksovirta, Hannu +68 more·2011·Neuron

Cited by (1,041)

Items 701–800 of 1,041

  1. Enteroviral Infection: The Forgotten Link to Amyotrophic Lateral Sclerosis?
    Yuan Chao Xue, Ralph Feuer, Neil R. Cashman, Honglin Luo · 2018 · Frontiers in Molecular Neuroscience
  2. Repeat-associated non-ATG (RAN) translation
    John Douglas Cleary, Amrutha Pattamatta, Laura P.W. Ranum · 2018 · Journal of Biological Chemistry
  3. Dysregulation of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis
    Yuan Chao Xue, Chen Seng Ng, Pinhao Xiang, Huitao Liu, Kevin Zhang, Yasir Mohamud, Honglin Luo · 2020 · Frontiers in Molecular Neuroscience
  4. ‘Costa da Morte’ ataxia is spinocerebellar ataxia 36: clinical and genetic characterization
    María García-Murias, Beatriz Quintáns, Manuel Arias, Ana Isabel Seixas, Pilar Cacheiro, Rosa Tarrı́o, Julio Pardo, María J. Millán, Susana Arias Rivas, Patricia Blanco et al. · 2012 · Brain
  5. Phosphorylated Tau as a Candidate Biomarker for Amyotrophic Lateral Sclerosis
    Grossman, Murray, Elman, Lauren, McCluskey, Leo, McMillan, Corey T., Boller, Ashley, Powers, John, Rascovsky, Katya, Hu, William, Shaw, Les, Irwin, David J. et al. · 2014 · JAMA Neurology
  6. Review: Prion‐like mechanisms of transactive response DNA binding protein of 43 kDa ( TDP ‐43) in amyotrophic lateral sclerosis ( ALS )
    Phillip Smethurst, Katie C. L. Sidle, John Hardy · 2014 · Neuropathology and Applied Neurobiology
  7. GGGGCC microsatellite RNA is neuritically localized, induces branching defects, and perturbs transport granule function
    Alondra Schweizer Burguete, Sandra Almeida, Fen‐Biao Gao, Robert Gordon Kalb, Michael R. Akins, Nancy M. Bonini · 2015 · eLife
  8. Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseases
    Milad Moloudizargari, Mohammad Hossein Asghari, Emad Ghobadi, Marjan Fallah, Shima Rasouli, Mohammad Reza Abdollahi · 2017 · Ageing Research Reviews
  9. C9orf72 -derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility
    Laura Fumagalli, Florence L. Young, Steven Boeynaems, Mathias De Decker, Arpan R. Mehta, Ann Swijsen, Raheem Fazal, Wenting Guo, Matthieu Moisse, Jimmy Beckers et al. · 2021 · Science Advances
  10. Heteromeric amyloid filaments of ANXA11 and TDP-43 in FTLD-TDP type C
    Diana Arseni, Takashi Nonaka, Max Henry Jacobsen, Alexey G. Murzin, Laura Cracco, Sew‐Yeu Peak‐Chew, Holly J. Garringer, Ito Kawakami, Hisaomi Suzuki, Misumoto Onaya et al. · 2024 · Nature
  11. The involvement of the cerebellum in amyotrophic lateral sclerosis
    Tino Prell, Julian Großkreutz · 2013 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  12. Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis
    Satoshi Yamashita, Yukio Ando · 2015 · Translational Neurodegeneration
  13. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration
    Gomez-Deza, Jorge, Lee, Youn-bok, Troakes, Claire, Nolan, Matthew, Al-Sarraj, Safa, Gallo, Jean-Marc, Shaw, Christopher E. · 2015 · Acta Neuropathologica Communications
  14. Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research
    Xiaowei Su, James Riley Broach, James R. Connor, Glenn S. Gerhard, Zachary Simmons · 2014 · Muscle & Nerve
  15. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
    Federica Rizzo, Giulietta Maria Riboldi, Sabrina Salani, Monica Nizzardo, Chiara Simone, Stefania Paola Corti, Eva Hedlund · 2013 · Cellular and Molecular Life Sciences
  16. Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72
    Mauricio Budini, Emanuele Buratti, Eugenia Morselli, Alfredo Criollo · 2017 · Frontiers in Molecular Neuroscience
  17. Small heat shock proteins in neurodegenerative diseases
    Leen Vendredy, Elias Adriaenssens, Vincent Timmerman · 2020 · Cell Stress and Chaperones
  18. Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS
    Kotaro Ogaki, Yuanzhe Li, Masashi Takanashi, Kei‐ichi Ishikawa, Tomonori Kobayashi, Takashi Nonaka, Masato Hasegawa, Masahiko Kishi, Hiroyo Yoshino, Manabu Funayama et al. · 2012 · Parkinsonism & Related Disorders
  19. Biomarkers in Neurodegenerative Diseases
    Jeromin, Andreas, Bowser, Robert · 2017 · Advances in Neurobiology
  20. In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers
    Mariely DeJesus‐Hernandez, NiCole A. Finch, Xue Wang, Tania F. Gendron, Kevin F. Bieniek, Michael G. Heckman, Aliaksei S. Vasilevich, Melissa Erin Murray, Linda Rousseau, Rachael E. Weesner et al. · 2017 · Acta Neuropathologica
  21. RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration
    Daisuke Ito, Mami Hatano, Norihiro Suzuki · 2017 · Science Translational Medicine
  22. Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis
    Francesca De Giorgio, Cheryl Maduro, Elizabeth Fisher, Abraham Acevedo‐Arozena · 2019 · Disease Models & Mechanisms
  23. An Intramolecular Salt Bridge Linking TDP43 RNA Binding, Protein Stability, and TDP43-Dependent Neurodegeneration
    Brittany N. Flores, Xingli Li, Ahmed Mujtaba Malik, Jose Martinez, Asim A. Beg, Sami J. Barmada · 2019 · Cell Reports
  24. Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD
    Nadja S. Andrade, Melina Ramic, Rustam Esanov, Wenjun Liu, Matthew J. Rybin, Gabriel Gaidosh, Abbas Abdallah, Samuel Del’Olio, Tyler C. Huff, Nancy T. Chee et al. · 2020 · Molecular Neurodegeneration
  25. Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation
    Gaetano Calabrese, Cristen M. Molzahn, Thibault Mayor · 2022 · Journal of Biological Chemistry
  26. Biological importance of arginine: A comprehensive review of the roles in structure, disorder, and functionality of peptides and proteins
    Munishwar Nath Gupta, Vladimir Nikolaevich Uversky · 2023 · International Journal of Biological Macromolecules
  27. Does a loss of TDP-43 function cause neurodegeneration?
    Zuoshang Xu · 2012 · Molecular Neurodegeneration
  28. Sqstm1 knock-down causes a locomotor phenotype ameliorated by rapamycin in a zebrafish model of ALS/FTLD
    Lattante, Serena, de Calbiac, Hortense, Le Ber, Isabelle, Brice, Alexis, Ciura, Sorana, Kabashi, Edor · 2015 · Human Molecular Genetics
  29. Cause or Effect: Misregulation of microRNA Pathways in Neurodegeneration
    Eduardo Gascon, Fen‐Biao Gao · 2012 · Frontiers in Neuroscience
  30. Cellular and physiological functions of C9ORF72 and implications for ALS/FTD
    Weilun Pang, Fenghua Hu · 2020 · Journal of Neurochemistry
  31. Nuclear export and translation of circular repeat-containing intronic RNA in C9ORF72-ALS/FTD
    Shaopeng Wang, Malgorzata J. Latallo, Zhe Zhang, Bo Huang, Dmitriy G. Bobrovnikov, Daoyuan Dong, Nathan M. Livingston, Wilson Tjoeng, Lindsey R. Hayes, Jeffrey D. Rothstein et al. · 2021 · Nature Communications
  32. Multimeric G-quadruplexes: A review on their biological roles and targeting
    Ilaria Frasson, Valentina Pirota, Sara N. Richter, Filippo Doria · 2022 · International Journal of Biological Macromolecules
  33. Genotype-phenotype correlations of amyotrophic lateral sclerosis
    Hong‐Fu Li, Zhi‐Ying Wu · 2016 · Translational Neurodegeneration
  34. C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity
    Youn‐Bok Lee, Pranetha Baskaran, Jorge Gómez-Deza, Han-Jou Chen, Agnes Lumi Nishimura, Bradley N. Smith, Claire Troakes, Yoshitsugu Adachi, Alan Stepto, Leonard Petrucelli et al. · 2017 · Human Molecular Genetics
  35. Clinical and Radiological Markers of Extra-Motor Deficits in Amyotrophic Lateral Sclerosis
    Foteini Christidi, Efstratios Karavasilis, Michail Rentzos, Nikolaos Kelekis, Ioannis Evdokimidis, Peter Bede · 2018 · Frontiers in Neurology
  36. Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis
    Emily P. McCann, Lyndal Henden, Jennifer A. Fifita, Katharine Y. Zhang, Natalie Grima, Denis C. Bauer, Sandrine Chan Moi Fat, Natalie A Twine, Roger Pamphlett, Matthew C. Kiernan et al. · 2020 · Journal of Medical Genetics
  37. Cortical Function in Asymptomatic Carriers and Patients WithC9orf72Amyotrophic Lateral Sclerosis
    Nimeshan Geevasinga, Parvathi Menon, Garth A. Nicholson, Karl Ng, James Howells, Jillian J. Kril, Con Yiannikas, Matthew C. Kiernan, Steve Vucic · 2015 · JAMA Neurology
  38. Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia
    Hieab H.H. Adams, Renée F.A.G. de Bruijn, Albert Hofman D, André Gerardus Uitterlinden, Cornelia M. van Duijn, Meike Willemijn Vernooij, Peter J. Koudstaal, M. Arfan Ikram · 2015 · Alzheimer s & Dementia
  39. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients
    Mahlon A. Collins, David Riascos, Tina Kovalik, Jiyan An, Kelly Krupa, Kristin Krupa, Brian L. Hood, Thomas P. Conrads, Alan Edward Renton, Bryan J. Traynor et al. · 2012 · Acta Neuropathologica
  40. Increasing MuSK Activity Delays Denervation and Improves Motor Function in ALS Mice
    M. Jose Pérez‐García, Steven J. Burden · 2012 · Cell Reports
  41. Diagnosis and Treatment of Chorea Syndromes
    Andreas Hermann, Ruth Helen Walker · 2015 · Current Neurology and Neuroscience Reports
  42. Amyotrophic lateral sclerosis: update and new developments
    J. Jefferson P. Perry, Ashley J. Pratt, Getzoff · 2012 · Degenerative Neurological and Neuromuscular Disease
  43. Hypermethylation of the CpG-island near the C9orf72 G₄C₂-repeat expansion in FTLD patients.
    Zhengrui Xi, I. Rainero, E. Rubino, L. Pinessi, A. Bruni, R. Maletta, B. Nacmias, S. Sorbi, D. Galimberti, E. Surace et al. · 2014 · Human Molecular Genetics
  44. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum
    Karch, Celeste M., Wen, Natalie, Fan, Chun C., Yokoyama, Jennifer S., Kouri, Naomi, Ross, Owen A., Höglinger, Gunter, Müller, Ulrich, Ferrari, Raffaele, Hardy, John et al. · 2018 · JAMA Neurology
  45. Genotype–phenotype links in frontotemporal lobar degeneration
    Sara Van Mossevelde, Sebastiaan Engelborghs, Julie van der Zee, Christine Van Broeckhoven · 2018 · Nature Reviews Neurology
  46. Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy
    Raygene Martier, Jolanda M.P. Liefhebber, Ana García‐Osta, Jana Miniarikova, Mar Cuadrado‐Tejedor, María Espelosin, Susana Ursúa, Harald Petry, Sander J. H. van Deventer, Melvin M. Evers et al. · 2019 · Molecular Therapy — Nucleic Acids
  47. Roles of non-canonical structures of nucleic acids in cancer and neurodegenerative diseases
    Hisae Tateishi‐Karimata, Naoki Sugimoto · 2021 · Nucleic Acids Research
  48. Brain modulation by the gut microbiota: From disease to therapy
    Mitra, Sarmistha, Dash, Raju, Nishan, Amena Al, Habiba, Sarmin Ummey, Moon, Il Soo · 2023 · Journal of Advanced Research
  49. Quantitative Assessment of Eye Phenotypes for Functional Genetic Studies Using Drosophila melanogaster
    Janani S. Iyer, Qingyu Wang, Thanh Le, Lucilla Pizzo, Sebastian Grönke, Surendra S. Ambegaokar, Yuzuru Imai, Ashutosh Srivastava, Beatriz Llamusí Troisí, Graeme Mardon et al. · 2016 · G3 Genes Genomes Genetics
  50. Genetics of Amyotrophic Lateral Sclerosis
    Gregory, Jenna M., Fagegaltier, Delphine, Phatnani, Hemali, Harms, Matthew B. · 2020 · Current Genetic Medicine Reports
  51. RNA-binding proteins in microsatellite expansion disorders: Mediators of RNA toxicity
    Gloria Vittone Echeverria, Thomas A. Cooper · 2012 · Brain Research
  52. Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1
    The ALSGEN Consortium · 2012 · Neurobiology of Aging
  53. A C9orf72 ALS/FTD Ortholog Acts in Endolysosomal Degradation and Lysosomal Homeostasis
    Anna Corrionero, Howard Robert Horvitz · 2018 · Current Biology
  54. Amyotrophic Lateral Sclerosis associated FUS mutation shortens mitochondria and induces neurotoxicity
    Tadashi Nakaya, Manolis Maragkakis · 2018 · Scientific Reports
  55. Neuroanatomical Quantitative Proteomics Reveals Common Pathogenic Biological Routes between Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
    Marina Iridoy, Irene Zubiri, María Victoria Zelaya, Leyre Martinez, Karina Ausín, Mercedes Lachén‐Montes, Enrique Santamaría, Joaquín Fernández‐Irigoyen, Ivonne Jericó · 2018 · International Journal of Molecular Sciences
  56. Nucleocytoplasmic transport defects in neurodegeneration — Cause or consequence?
    Saskia Hutten, Dorothee Dormann · 2019 · Seminars in Cell and Developmental Biology
  57. Fluid biomarkers for amyotrophic lateral sclerosis: a review
    Katherine E. Irwin, Udit Sheth, Philip C. Wong, Tania F. Gendron · 2024 · Molecular Neurodegeneration
  58. Young-onset amyotrophic lateral sclerosis: historical and other observations
    Martin R. Turner, J. Barnwell, Ammar Al‐Chalabi, Andrew Eisen · 2012 · Brain
  59. Recent advances in amyotrophic lateral sclerosis
    Nilo Riva, Federica Agosta, Christian Lunetta, Massimo Filippi, Angelo Quattrini · 2016 · Journal of Neurology
  60. Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population
    Mfon E. Umoh, Christina Nicole Fournier, Yingjie Li, Meraida A. Polak, Latoya Shaw, John E. Landers, William T. Hu, Marla Gearing, Jonathan D. Glass · 2016 · Neurology
  61. A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts
    Caroline Ingre, John E. Landers, Naji Rizik, Alexander Erich Volk, Chizuru Akimoto, Anna Birve, Annemarie Hübers, Pamela J. Keagle, Katarzyna Piotrowska, Rayomand Press et al. · 2012 · Neurobiology of Aging
  62. Rab8, POSH, and TAK1 regulate synaptic growth in a Drosophila model of frontotemporal dementia
    Ryan J. H. West, Yubing Lu, Bruno Marie, Fen‐Biao Gao, Sean T. Sweeney · 2015 · The Journal of Cell Biology
  63. Genetics of neuromuscular disorders
    Nigel G. Laing · 2012 · Critical Reviews in Clinical Laboratory Sciences
  64. Ubiquilin 2mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia
    Cinzia Gellera, Cinzia Tiloca, Roberto Del Bo, Lucia Corrado, Viviana Pensato, Jennifer Agostini, Cristina Cereda, Antonia Ratti, Barbara Castellotti, Stefania Paola Corti et al. · 2012 · Journal of Neurology Neurosurgery & Psychiatry
  65. Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72
    Takuya Konno, Atsushi Shiga, Akira Tsujino, Akihiro Sugai, Taisuke Kato, Kazuaki Kanai, Akio Yokoseki, Hiroto Eguchi, Satoshi Kuwabara, Masatoyo Nishizawa et al. · 2012 · Journal of Neurology Neurosurgery & Psychiatry
  66. RNA-mediated toxicity in neurodegenerative disease
    Véronique Belzil, Tania F. Gendron, Leonard Petrucelli · 2012 · Molecular and Cellular Neuroscience
  67. The Glycine-Alanine Dipeptide Repeat from C9orf72 Hexanucleotide Expansions Forms Toxic Amyloids Possessing Cell-to-Cell Transmission Properties
    Yu‐Jen Chang, U‐Ser Jeng, Ya‐Ling Chiang, Ing‐Shouh Hwang, Yun‐Ru Chen · 2016 · Journal of Biological Chemistry
  68. Antibodies inhibit transmission and aggregation of C9orf72 poly‐GA dipeptide repeat proteins
    Qihui Zhou, Carina Lehmer, Meike Michaelsen, Kohji Mori, Dominik Alterauge, Dirk Baumjohann, Martin H. Schludi, Johanna Greiling, Daniel Farny, Andrew Flatley et al. · 2017 · EMBO Molecular Medicine
  69. C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect
    Antonia Ratti, Lucia Corrado, Barbara Castellotti, Roberto Del Bo, Isabella Fogh, Cristina Cereda, Cinzia Tiloca, Carla D’Ascenzo, Alessandra Bagarotti, Viviana Pensato et al. · 2012 · Neurobiology of Aging
  70. The multifaceted role of glial cells in amyotrophic lateral sclerosis
    Chiara F. Valori, Liliana Brambilla, Francesca Martorana, Daniela Rossi · 2013 · Cellular and Molecular Life Sciences
  71. On the Role of Store-Operated Calcium Entry in Acute and Chronic Neurodegenerative Diseases
    Agnese Secondo, Giacinto Bagetta, Diana Amantea · 2018 · Frontiers in Molecular Neuroscience
  72. Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis
    Shuo‐Chien Ling, Somasish Ghosh Dastidar, Seiya Tokunaga, Wan Yun Ho, Kenneth Lim, Hristelina S. Ilieva, Philippe A. Parone, Sheue-Houy Tyan, Tsemay M. Tse, Jer‐Cherng Chang et al. · 2019 · eLife
  73. Partial inhibition of the overactivated Ku80-dependent DNA repair pathway rescues neurodegeneration in C9ORF72 -ALS/FTD
    Rodrigo Lopez-Gonzalez, Dejun Yang, Mochtar Pribadi, Tanya S. Kim, Gopinath Krishnan, So Yoen Choi, Soojin Lee, Giovanni Coppola, Fen‐Biao Gao · 2019 · Proceedings of the National Academy of Sciences
  74. The genetic architecture of ALS
    Aleksey Shatunov, Ammar Al‐Chalabi · 2020 · Neurobiology of Disease
  75. Combating deleterious phase transitions in neurodegenerative disease
    April L. Darling, James Shorter · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  76. Metabolic Aspects of Adenosine Functions in the Brain
    Mercedes Garcia‐Gil, Marcella Camici, S. Allegrini, Rossana Pesi, Maria Grazia Tozzi · 2021 · Frontiers in Pharmacology
  77. Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis
    Francesca Luisa Conforti, Rossella Spataro, William Sproviero, Rosalucia Mazzei, Francesca Cavalcanti, Francesca Condino, Isabella Laura Simone, Giancarlo Logroscino, Alessandra Patitucci, Angela Magariello et al. · 2012 · Neurology
  78. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis
    Scott P. Allen, Sandeep Sundara Rajan, Lynn Duffy, Heather Mortiboys, Adrian Higginbottom, Andrew J. Grierson, Pamela J. Shaw · 2013 · Neurobiology of Aging
  79. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death
    Shangxi Xiao, Teresa R. Sanelli, Helen Yu-Shan Chiang, Yulong Sun, Avijit Chakrabartty, Julia Lee Keith, Ekaterina A. Rogaeva, Lorne H. Zinman, Janice Robertson · 2015 · Acta Neuropathologica
  80. A C9orf72–CARM1 axis regulates lipid metabolism under glucose starvation-induced nutrient stress
    Yang Liu, Tao Wang, Yon Ju Ji, Kenji Johnson, Honghe Liu, Kaitlin Johnson, Scott Bailey, Yongwon Suk, Yuning Lu, Mingming Liu et al. · 2018 · Genes & Development
  81. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD
    Starr, Alexander, Sattler, Rita · 2018 · Brain Research
  82. Fuchs Endothelial Corneal Dystrophy: Update on Pathogenesis and Future Directions
    Caterina Sarnicola, Asim V. Farooq, Kathryn A. Colby · 2018 · Eye & Contact Lens Science & Clinical Practice
  83. Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism
    Erin G. Conlon, Delphine Fagegaltier, Phaedra Agius, Julia Davis‐Porada, James A. Gregory, Isabel Hubbard, Kristy Kang, Duyang Kim, Hemali P. Phatnani, Justin Y. Kwan et al. · 2018 · eLife
  84. Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition
    Katarina Stoklund Dittlau, Emily N. Krasnow, Laura Fumagalli, Tijs Vandoorne, Pieter Baatsen, Axelle Kerstens, Giorgia Giacomazzi, Benjamin Pavie, Elisabeth Rossaert, Jimmy Beckers et al. · 2021 · Stem Cell Reports
  85. Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis
    Christina Schuster, Elisabeth Kasper, Martin Dyrba, Judith Machts, Daniel Bittner, Jörn Kaufmann, Alex J. Mitchell, R. Benecke, Stefan Johannes Teipel, Stefan Vielhaber et al. · 2013 · Neurobiology of Aging
  86. The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion
    Emma M. Devenney, Ramón Landín-Romero, Muireann Irish, Michael Hornberger, Eneida Mioshi, Glenda Margaret Halliday, Matthew C. Kiernan, John R. Hodges · 2016 · NeuroImage Clinical
  87. Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder
    Elisabetta Zucchi, Nicola Ticozzi, Jessica Mandrioli · 2019 · Frontiers in Neuroscience
  88. Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians
    Martin A. Kohli, Krista John‐Williams, Ruchita Rajbhandary, Adam Christian Naj, Patrice L. Whitehead, Kara Hamilton, Regina M. Carney, Clinton B. Wright, Elizabeth Crocco, Harry E. Gwirtzman et al. · 2012 · Neurobiology of Aging
  89. Proteostasis impairment in ALS
    Céline Ruegsegger, Smita Saxena · 2016 · Brain Research
  90. The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future
    Heike J. Wobst, Korrie L. Mack, Dean G. Brown, Nicholas J. Brandon, James Shorter · 2020 · Medicinal Research Reviews
  91. CYLD is a causative gene for frontotemporal dementia – amyotrophic lateral sclerosis
    Carol Dobson‐Stone, Marianne Hallupp, Hamideh Shahheydari, Audrey Ragagnin, Zac Chatterton, Francine Carew‐Jones, Claire E. Shepherd, Holly Stefen, Esmeralda Parić, Thomas Fath et al. · 2020 · Brain
  92. Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study
    Leonard H. van den Berg, Jeffrey D. Rothstein, Pamela J. Shaw, Suma Babu, Michael Benatar, Robert C. Bucelli, Angela L. Genge, Jonathan D. Glass, Orla M. Hardiman, Vincenzo Libri et al. · 2024 · The Lancet Neurology
  93. Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations
    Philippe Corcia, Paul N. Valdmanis, Stéphanie Millecamps, C. Lionnet, Hélène Blasco, Kévin Mouzat, Hussein Daoud, Véronique Belzil, Raul Juntas Morales, N. Pageot et al. · 2012 · Neurology
  94. Psychiatric Presentations of <i>C9orf72</i> Mutation: What Are the Diagnostic Implications for Clinicians?
    Ducharme, Simon, Bajestan, Sepideh, Dickerson, Bradford C., Voon, Valerie · 2017 · The Journal of Neuropsychiatry and Clinical Neurosciences
  95. New developments in RAN translation: insights from multiple diseases
    John Douglas Cleary, Laura P.W. Ranum · 2017 · Current Opinion in Genetics & Development
  96. C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies
    Sarat C. Vatsavayai, Alissa L. Nana, Jennifer S. Yokoyama, William W. Seeley · 2018 · Acta Neuropathologica
  97. Nucleocytoplasmic Proteomic Analysis Uncovers eRF1 and Nonsense-Mediated Decay as Modifiers of ALS/FTD C9orf72 Toxicity
    Juan Alberto Ortega, Elizabeth L. Daley, Sukhleen Kour, Marisa Samani, Liana Tellez, Haley S. Smith, Elizabeth Hall, Y. Taylan Esengul, Yung‐Hsu Tsai, Tania F. Gendron et al. · 2020 · Neuron
  98. TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway
    Diane Moujalled, Alexandra Grubman, Karla M. Acevedo, Shu Yang, Yazi Diana Ke, Donia M. Moujalled, Clare Duncan, Aphrodite Caragounis, Nirma D. Perera, Bradley J. Turner et al. · 2017 · Human Molecular Genetics
  99. Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model
    Cook, Casey, Kang, Silvia S., Carlomagno, Yari, Lin, Wen-Lang, Yue, Mei, Kurti, Aishe, Shinohara, Mitsuru, Jansen-West, Karen, Perkerson, Emilie, Castanedes-Casey, Monica et al. · 2015 · Human Molecular Genetics
  100. C9ORF72 repeat expansions in cases with previously identified pathogenic mutations
    Marka van Blitterswijk, Matthew Baker, Mariely DeJesus‐Hernandez, Roberta Ghidoni, Luisa Benussi, Elizabeth C. Finger, Ging‐Yuek Robin Hsiung, Brendan J. Kelley, Melissa Erin Murray, Nicola J. Rutherford et al. · 2013 · Neurology